NCT05660681 - Evaluation of the Tolerability and Efficacy of CWT-f-002 Lubricant Eye Drops | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

December 12, 2022

Primary Completion Date

August 15, 2023

Study Completion Date

August 15, 2023

Conditions

Dry Eye Disease

Interventions

DRUG

glycerin 0.7%/PEG 400 0.3%

Eye drop with active agents from the OTC Monograph.

DRUG

polyethylene glycol 400 0.4%/propylene glycol 0.3%

Eye drop with active agents from the OTC Monograph.

Trial Locations (1)

Andover Research Eye Institute, Andover